{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:53:29Z","timestamp":1791500009847,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K06268"],"award-info":[{"award-number":["23K06268"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.dmpk.2026.101542","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:20:54Z","timestamp":1780068054000},"page":"101542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tyrosine kinase inhibitors suppress cytochrome P450 2C8 and 2J2 functions and their expression in renal cell carcinoma"],"prefix":"10.1016","volume":"71","author":[{"given":"Ayaka","family":"Kojima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nadai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1068-4261","authenticated-orcid":false,"given":"Hiroshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0825-6097","authenticated-orcid":false,"given":"Miki","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.dmpk.2026.101542_bib1","first-page":"7923","article-title":"CYP2J2 promotes the development of hepatocellular carcinoma by increasing the EETs production to improve HIF-1alpha stability","volume":"12","author":"Gui","year":"2020","journal-title":"Am J Transl Res"},{"issue":"2","key":"10.1016\/j.dmpk.2026.101542_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0003-9861(95)90023-3","article-title":"Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes","volume":"320","author":"Rifkind","year":"1995","journal-title":"Arch Biochem Biophys"},{"issue":"51","key":"10.1016\/j.dmpk.2026.101542_bib3","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1021\/acs.biochem.7b01025","article-title":"Arachidonic acid metabolism by human cardiovascular CYP2J2 is modulated by doxorubicin","volume":"56","author":"Arnold","year":"2017","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.dmpk.2026.101542_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1124\/pr.115.011411","article-title":"Role of cytochrome P450 2C8 in drug metabolism and interactions","volume":"68","author":"Backman","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.dmpk.2026.101542_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/03602532.2013.806537","article-title":"Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance","volume":"45","author":"Xu","year":"2013","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.dmpk.2026.101542_bib6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1186\/1471-2407-14-841","article-title":"Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer","volume":"14","author":"Wei","year":"2014","journal-title":"BMC Cancer"},{"issue":"14","key":"10.1016\/j.dmpk.2026.101542_bib7","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1158\/0008-5472.CAN-06-3643","article-title":"Cytochrome p450 epoxygenase promotes human cancer metastasis","volume":"67","author":"Jiang","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.dmpk.2026.101542_bib8","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/ndt\/gfae036","article-title":"Global epidemiology of kidney cancer","volume":"39","author":"Cirillo","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.dmpk.2026.101542_bib9","doi-asserted-by":"crossref","first-page":"858","DOI":"10.20517\/cdr.2023.89","article-title":"Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma","volume":"6","author":"Sweeney","year":"2023","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.dmpk.2026.101542_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3771866","article-title":"CYP2J2 is a diagnostic and prognostic biomarker associated with immune infiltration in kidney renal clear cell carcinoma","volume":"2021","author":"Zou","year":"2021","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.dmpk.2026.101542_bib11","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1080\/00498254.2024.2389401","article-title":"Effects of tyrosine kinase inhibitors used for the treatment of non-small cell lung carcinoma on cytochrome P450 2J2 activities","volume":"54","author":"Kojima","year":"2024","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmpk.2026.101542_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2025.101501","article-title":"Tyrosine kinase inhibitors, nilotinib and radotinib, suppress both catalytic function and mRNA expression of human cytochrome P450 2J2 and 2C8","volume":"65","author":"Kojima","year":"2025","journal-title":"Drug Metab Pharmacokinet"},{"issue":"8","key":"10.1016\/j.dmpk.2026.101542_bib29","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/nu9080858","article-title":"Suppression of Wnt signaling and osteogenic changes in vascular smooth muscle cells by eicosapentaenoic acid","volume":"9","author":"Saito","year":"2017","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.dmpk.2026.101542_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/REP-13-0087","article-title":"Aberrant expression and regulation of NR2F2 and CTNNB1 in uterine fibroids","volume":"146","author":"Zaitseva","year":"2013","journal-title":"Reproduction"},{"issue":"6","key":"10.1016\/j.dmpk.2026.101542_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/(SICI)1099-0461(1999)13:6<289::AID-JBT1>3.0.CO;2-N","article-title":"Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs","volume":"13","author":"Klose","year":"1999","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"10.1016\/j.dmpk.2026.101542_bib32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3892\/ol.2022.13300","article-title":"Artemether inhibits proliferation, invasion and migration of hepatocellular carcinoma cells via targeting of CYP2J2","volume":"23","author":"Zhu","year":"2022","journal-title":"Oncol Lett"},{"issue":"3","key":"10.1016\/j.dmpk.2026.101542_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/molpharm.122.000568","article-title":"Valproic acid-induced upregulation of multidrug efflux transporter ABCG2\/BCRP via PPAR \u03b1-dependent mechanism in human brain endothelial cells","volume":"103","author":"Kukal","year":"2023","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.dmpk.2026.101542_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12094-012-0904-1","article-title":"Identification of valid reference housekeeping genes for gene expression analysis in tumor neovascularization studies","volume":"15","author":"Rienzo","year":"2013","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.dmpk.2026.101542_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fphar.2015.00261","article-title":"Peroxisome proliferator-activated receptor alpha, PPAR\u03b1, directly regulates transcription of cytochrome P450 CYP2C8","volume":"6","author":"Thomas","year":"2015","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.dmpk.2026.101542_bib14","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/oby.21115","article-title":"CYP2J2 overexpression ameliorates hyperlipidemia via increased fatty acid oxidation mediated by the AMPK pathway","volume":"23","author":"Zhang","year":"2015","journal-title":"Obesity"},{"issue":"26","key":"10.1016\/j.dmpk.2026.101542_bib15","doi-asserted-by":"crossref","first-page":"43458","DOI":"10.18632\/oncotarget.16465","article-title":"In-vivo relation between plasma concentration of sorafenib and its safety in Chinese patients with metastatic renal cell carcinoma: a single-center clinical study","volume":"8","author":"Mai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.dmpk.2026.101542_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116169","article-title":"Sorafenib reduces the production of epoxyeicosatrienoic acids and leads to cardiac injury by inhibiting CYP2J in rats","volume":"223","author":"Zhang","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"10.1016\/j.dmpk.2026.101542_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40262-013-0068-3","article-title":"Clinical pharmacology of axitinib","volume":"52","author":"Chen","year":"2013","journal-title":"Clin Pharmacokinet"},{"issue":"39","key":"10.1016\/j.dmpk.2026.101542_bib18","doi-asserted-by":"crossref","first-page":"36059","DOI":"10.1074\/jbc.R100030200","article-title":"Epoxygenase pathways of arachidonic acid metabolism","volume":"276","author":"Zeldin","year":"2001","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.dmpk.2026.101542_bib19","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.2174\/1568026611313120007","article-title":"CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapy","volume":"13","author":"Chen","year":"2013","journal-title":"Curr Top Med Chem"},{"issue":"Pt 23","key":"10.1016\/j.dmpk.2026.101542_bib20","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1242\/jcs.02674","article-title":"Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis","volume":"118","author":"Michaelis","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.dmpk.2026.101542_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.plipres.2013.11.003","article-title":"Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer","volume":"53","author":"Zhang","year":"2014","journal-title":"Prog Lipid Res"},{"issue":"6","key":"10.1016\/j.dmpk.2026.101542_bib22","first-page":"462","article-title":"14,15-Epoxyeicosatrienoic acid induces the proliferation and anti- apoptosis of human carcinoma cell","volume":"19","author":"Zhang","year":"2011","journal-title":"Daru"},{"issue":"1\u20132","key":"10.1016\/j.dmpk.2026.101542_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.prostaglandins.2010.06.004","article-title":"14,15-Epoxyeicosatrienoic acid induces vasorelaxation through the prostaglandin EP(2) receptors in rat mesenteric artery","volume":"93","author":"Yang","year":"2010","journal-title":"Prostag Other Lipid Mediat"},{"issue":"3","key":"10.1016\/j.dmpk.2026.101542_bib24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/bcp.12149","article-title":"Incidence and risk of hypertension with a novel multi-targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta-analysis","volume":"76","author":"Qi","year":"2013","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.dmpk.2026.101542_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/jch.12273","article-title":"Incidence and risk of sorafenib-induced hypertension: a systematic review and meta-analysis","volume":"16","author":"Li","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"5\u20136","key":"10.1016\/j.dmpk.2026.101542_bib26","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000503884","article-title":"Berberine induces CYP2J2 expression in human U251 glioma cells via regulation of peroxisome proliferator-activated receptor alpha","volume":"105","author":"Yu","year":"2020","journal-title":"Pharmacology"},{"issue":"6","key":"10.1016\/j.dmpk.2026.101542_bib27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1124\/mol.114.097402","article-title":"Activating and inhibitory functions of WNT\/\u03b2-catenin in the induction of cytochromes P450 by nuclear receptors in HepaRG cells","volume":"87","author":"Thomas","year":"2015","journal-title":"Mol Pharmacol"},{"issue":"24","key":"10.1016\/j.dmpk.2026.101542_bib28","doi-asserted-by":"crossref","first-page":"21657","DOI":"10.1074\/jbc.M200139200","article-title":"Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling","volume":"277","author":"Leung","year":"2002","journal-title":"J Biol Chem"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436726000285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436726000285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:39:20Z","timestamp":1791499160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436726000285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":34,"alternative-id":["S1347436726000285"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2026.101542","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tyrosine kinase inhibitors suppress cytochrome P450 2C8 and 2J2 functions and their expression in renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2026.101542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101542"}}